These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10375966)

  • 1. [Detection of activated platelets by flow cytometry].
    Kohmura C; Hayashi Y; Ikeda H
    Rinsho Byori; 1999 May; 47(5):447-52. PubMed ID: 10375966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
    Nurden P; Bihour C; Smith M; Raymond JM; Nurden AT
    Am J Hematol; 1996 Jan; 51(1):79-84. PubMed ID: 8571943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of fibrinogen binding to platelets by flow cytometry: evaluation method for reflecting platelet activation].
    Ishikawa S; Tozuka M; Hirota M; Sasaki Y; Okumura N; Furihata K; Katsuyama T
    Rinsho Byori; 1998 Jun; 46(6):605-10. PubMed ID: 9691771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine diphosphate-induced platelet aggregation correlates with platelet activation identified with the use of flow cytometry.
    García M; Schneider DJ
    Pathophysiol Haemost Thromb; 2008; 36(2):75-9. PubMed ID: 19127086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
    J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
    Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.
    Lim YA; Cho SR; Lee WG; Park JS; Kim SW
    Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry.
    Hu H; Forslund M; Li N
    Thromb Res; 2005; 116(3):241-7. PubMed ID: 15935833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia.
    Panzer S; Höcker L; Vormittag R; Rieger M; Koren D; Dunkler D; Pabinger I
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):694-6. PubMed ID: 16933254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation.
    Lindahl TL; Festin R; Larsson A
    Thromb Haemost; 1992 Aug; 68(2):221-5. PubMed ID: 1412170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
    Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression.
    Klinkhardt U; Wenzel E; Harder S
    Platelets; 2006 Feb; 17(1):42-8. PubMed ID: 16308186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of fibrinogen binding to porcine platelets by flow cytometry: a method for studies of porcine platelet activation.
    Larsson A; Eriksson M; Lindahl TL
    Platelets; 2002 May; 13(3):153-7. PubMed ID: 12180497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-383 (tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor.
    Barlage S; Wimmer A; Pfeiffer A; Rothe G; Schmitz G
    Platelets; 2002 May; 13(3):133-40. PubMed ID: 12180495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.